Terms: = Uterine cancer AND TP53, TRP53, 7157, ENSG00000141510, P04637, LFS1, P53 AND Staging
85 results:
1. PAD-mediated citrullination is a novel candidate diagnostic marker and druggable target for HPV-associated cervical cancer.
Albano C; Biolatti M; Mazibrada J; Pasquero S; Gugliesi F; Lo Cigno I; Calati F; Bajetto G; Riva G; Griffante G; Landolfo S; Gariglio M; De Andrea M; Dell'Oste V
Front Cell Infect Microbiol; 2024; 14():1359367. PubMed ID: 38529474
[TBL] [Abstract] [Full Text] [Related]
2. To study the expression of estrogen, progesterone receptor and p53 immunohistochemistry markers in subtyping endometrial carcinoma.
Yadav A; Sistla A; Swain M; Gowrishankar S; Padua M; Modi T; Himabindu R; Agarwal N; Kulkarni A; Bhandari T; Vudayaraju H; Chinnababu ; Reddy VA
Indian J Pathol Microbiol; 2024; 67(1):62-67. PubMed ID: 38358190
[TBL] [Abstract] [Full Text] [Related]
3. Dedifferentiated Leiomyosarcoma-morphology, Immunohistochemistry, and Molecular Findings of a Case and Review of Literature.
Kousar A; Wald AI; Heayn M; Cardillo ND; Elishaev E; Bhargava R
Int J Gynecol Pathol; 2024 May; 43(3):264-270. PubMed ID: 37922938
[TBL] [Abstract] [Full Text] [Related]
4. Utility of the revised FIGO2023 staging with molecular classification in endometrial cancer.
Kobayashi-Kato M; Fujii E; Asami Y; Ahiko Y; Hiranuma K; Terao Y; Matsumoto K; Ishikawa M; Kohno T; Kato T; Shiraishi K; Yoshida H
Gynecol Oncol; 2023 Nov; 178():36-43. PubMed ID: 37748269
[TBL] [Abstract] [Full Text] [Related]
5. Extrauterine Mesonephric-like Carcinoma: A Comprehensive Single Institution Study of 33 Cases.
Euscher ED; Marques-Piubelli ML; Ramalingam P; Wistuba I; Lawson BC; Frumovitz M; Malpica A
Am J Surg Pathol; 2023 Jun; 47(6):635-648. PubMed ID: 37026792
[TBL] [Abstract] [Full Text] [Related]
6. [Expression and significance of immune checkpoint B7-homolog 4 in endometrial cancer].
Zong LJ; Xiang Y; Yu SN; Lu ZH; Chen J; Huang WH
Zhonghua Fu Chan Ke Za Zhi; 2022 Dec; 57(12):921-931. PubMed ID: 36562226
[No Abstract] [Full Text] [Related]
7. [Molecular-integrated risk profile: An opportunity for therapeutic de-escalation in intermediate and high-intermediate risk endometrial cancer].
Espenel S; Pointreau Y; Genestie C; Durdux C; Haie-Meder C; Chargari C
Cancer Radiother; 2022 Oct; 26(6-7):931-937. PubMed ID: 36031498
[TBL] [Abstract] [Full Text] [Related]
8. [The influence of molecular classification in the selection of postoperative adjuvant therapy in endometrial carcinoma].
Yan XS; Li M; Liang HM; Guo HY; Wu Y; He HJ; Zhang K; Li H
Zhonghua Yi Xue Za Zhi; 2022 Aug; 102(32):2500-2505. PubMed ID: 36008320
[No Abstract] [Full Text] [Related]
9. Hybrid PET/MRI in staging Endometrial cancer: Diagnostic and Predictive Value in a Prospective Cohort.
Ironi G; Mapelli P; Bergamini A; Fallanca F; Candotti G; Gnasso C; Taccagni GL; Sant'Angelo M; Scifo P; Bezzi C; Bettinardi V; Rancoita PMV; Mangili G; Bocciolone L; Candiani M; Gianolli L; De Cobelli F; Picchio M
Clin Nucl Med; 2022 Mar; 47(3):e221-e229. PubMed ID: 35067539
[TBL] [Abstract] [Full Text] [Related]
10. Corded and Hyalinized and Spindled Endometrioid Endometrial Carcinoma: A Clinicopathologic and Molecular Analysis of 9 Tumors Based on the TCGA Classifier.
Safdar NS; Thompson EF; Gilks CB; Isacson C; Bennett JA; Clarke B; Young RH; Oliva E
Am J Surg Pathol; 2021 Aug; 45(8):1038-1046. PubMed ID: 34115671
[TBL] [Abstract] [Full Text] [Related]
11. Immunohistochemical biomarkers are prognostic relevant in addition to the ESMO-ESGO-ESTRO risk classification in endometrial cancer.
Vrede SW; van Weelden WJ; Visser NCM; Bulten J; van der Putten LJM; van de Vijver K; Santacana M; Colas E; Gil-Moreno A; Moiola CP; Mancebo G; Krakstad C; Trovik J; Haldorsen IS; Huvila J; Koskas M; Weinberger V; Bednarikova M; Hausnerova J; van der Wurff AA; Matias-Guiu X; Amant F; ; Snijders MPLM; Küsters-Vandevelde HVN; Reijnen C; Pijnenborg JMA
Gynecol Oncol; 2021 Jun; 161(3):787-794. PubMed ID: 33858677
[TBL] [Abstract] [Full Text] [Related]
12. [What's new in the management of endometrial cancer? Update on the new European recommendations for 2021].
Azaïs H; Lecointre L; Canlorbe G;
Gynecol Obstet Fertil Senol; 2021 Sep; 49(9):691-697. PubMed ID: 33757927
[TBL] [Abstract] [Full Text] [Related]
13. Molecular characterization in the prediction of disease extent in endometrial carcinoma.
Kolehmainen AM; Pasanen AM; Koivisto-Korander RL; Bützow RC; Loukovaara MJ
Eur J Obstet Gynecol Reprod Biol; 2021 Jan; 256():478-483. PubMed ID: 33189427
[TBL] [Abstract] [Full Text] [Related]
14. POLE mutation combined with microcystic, elongated and fragmented (MELF) pattern invasion in endometrial carcinomas might be associated with poor survival in Chinese women.
He D; Wang H; Dong Y; Zhang Y; Zhao J; Lv C; Zheng X; Li D; Li T
Gynecol Oncol; 2020 Oct; 159(1):36-42. PubMed ID: 32800323
[TBL] [Abstract] [Full Text] [Related]
15. CTNNB1 Mutations and Aberrant β-Catenin Expression in Ovarian Endometrioid Carcinoma: Correlation With Patient Outcome.
Zyla RE; Olkhov-Mitsel E; Amemiya Y; Bassiouny D; Seth A; Djordjevic B; Nofech-Mozes S; Parra-Herran C
Am J Surg Pathol; 2021 Jan; 45(1):68-76. PubMed ID: 32769429
[TBL] [Abstract] [Full Text] [Related]
16. Endometrial cancer Molecular Risk Stratification is Equally Prognostic for Endometrioid Ovarian Carcinoma.
Krämer P; Talhouk A; Brett MA; Chiu DS; Cairns ES; Scheunhage DA; Hammond RFL; Farnell D; Nazeran TM; Grube M; Xia Z; Senz J; Leung S; Feil L; Pasternak J; Dixon K; Hartkopf A; Krämer B; Brucker S; Heitz F; du Bois A; Harter P; Kommoss FKF; Sinn HP; Heublein S; Kommoss F; Vollert HW; Manchanda R; de Kroon CD; Nijman HW; de Bruyn M; Thompson EF; Bashashati A; McAlpine JN; Singh N; Tinker AV; Staebler A; Bosse T; Kommoss S; Köbel M; Anglesio MS
Clin Cancer Res; 2020 Oct; 26(20):5400-5410. PubMed ID: 32737030
[TBL] [Abstract] [Full Text] [Related]
17. CircAGFG1 aggravates the progression of cervical cancer by downregulating p53.
Wang XH; Li J
Eur Rev Med Pharmacol Sci; 2020 Feb; 24(4):1704-1711. PubMed ID: 32141537
[TBL] [Abstract] [Full Text] [Related]
18. [Clinicopathological features of stratified mucin-producing neoplastic lesions of the cervix].
Xu H; Wang YM; Zhang J
Zhonghua Bing Li Xue Za Zhi; 2020 Jan; 49(1):28-33. PubMed ID: 31914531
[No Abstract] [Full Text] [Related]
19. A proposal for updating the staging of endometrial cancer.
Maheshwari A; Gupta S; Prat J
Int J Gynaecol Obstet; 2019 May; 145(2):245-252. PubMed ID: 30776091
[TBL] [Abstract] [Full Text] [Related]
20. L1 Cell Adhesion Molecule (L1CAM) expression in endometrioid endometrial carcinomas: A possible pre-operative surrogate of lymph vascular space invasion.
de Freitas D; Aguiar FN; Anton C; Bacchi CE; Carvalho JP; Carvalho FM
PLoS One; 2018; 13(12):e0209294. PubMed ID: 30557309
[TBL] [Abstract] [Full Text] [Related]
[Next]
